TANDEM DIABETES CARE INC
TNDMNasdaq
$17.08
↑ +4.8%Jul 17 close · end-of-day
Price
1Y↑ +8.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.2B
Enterprise Value
$1.2B
P/E
—
P/S
1.1
P/B
8.8
EV/EBITDA
—
PEG
—
FCF Yield
-0.3%
Dividend Yield
—
Revenue (TTM)
$1.0B
Net Income (TTM)
-$94.5M
Free Cash Flow (TTM)
-$3.6M
Gross Margin
54.9%
Operating Margin
-8.2%
Net Margin
-9.2%
ROE
-71.4%
ROIC
-40.4%
Debt / Equity
4.5
Net Cash
-$31.5M
Return 1Y
+11.2%
Company profile
Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.
- CEO
- John F. Sheridan
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 2,600
- Headquarters
- California
- Website
- tandemdiabetes.com
Earnings
TNDM Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$247.2M↑ +5.5%
Diluted EPS-$0.30↓ -84.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $498.8M | $702.8M | $801.2M | $747.7M | $940.2M | $1.0B |
| Gross profit | $260.5M | $376.2M | $413.0M | $367.7M | $489.6M | $546.0M |
| Operating income | -$8.0M | $22.7M | -$92.8M | -$233.2M | -$99.1M | -$187.3M |
| Net income | -$34.4M | $15.6M | -$94.6M | -$222.6M | -$96.0M | -$204.7M |
| Diluted EPS | -$0.56 | $0.24 | -$1.47 | -$3.43 | -$1.47 | -$3.04 |
| Operating cash flow | $24.7M | $111.4M | $50.5M | -$31.8M | $24.2M | -$9.7M |
| Free cash flow | -$2.7M | $97.2M | $16.4M | -$58.6M | $5.0M | -$29.7M |
| Gross margin | 52.2% | 53.5% | 51.5% | 49.2% | 52.1% | 53.8% |
| Operating margin | -1.6% | 3.2% | -11.6% | -31.2% | -10.5% | -18.5% |
| Net margin | -6.9% | 2.2% | -11.8% | -29.8% | -10.2% | -20.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $221.9M | $244.0M | $282.6M | $234.4M | $240.7M | $249.3M | $290.4M | $247.2M |
| Gross profit | $112.8M | $124.7M | $157.5M | $118.4M | $125.9M | $134.3M | $167.5M | $136.8M |
| Operating income | -$30.8M | -$26.1M | -$581,000.00 | -$120.9M | -$51.8M | -$22.9M | $8.3M | -$17.4M |
| Net income | -$30.8M | -$23.3M | $755,000.00 | -$130.6M | -$52.4M | -$21.2M | -$589,000.00 | -$20.4M |
| Diluted EPS | -$0.47 | -$0.35 | $0.01 | -$1.97 | -$0.78 | -$0.31 | -$0.01 | -$0.30 |
| Operating cash flow | -$5.3M | $26.8M | $10.7M | -$18.3M | -$9.5M | $8.3M | $9.8M | $11.1M |
| Free cash flow | -$11.7M | $21.5M | $7.6M | -$21.2M | -$15.7M | $4.2M | $3.1M | $4.8M |
| Gross margin | 50.8% | 51.1% | 55.7% | 50.5% | 52.3% | 53.9% | 57.7% | 55.3% |
| Operating margin | -13.9% | -10.7% | -0.2% | -51.6% | -21.5% | -9.2% | 2.9% | -7.1% |
| Net margin | -13.9% | -9.5% | 0.3% | -55.7% | -21.8% | -8.5% | -0.2% | -8.2% |
Company news
Jul 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.